Research ArticleOriginal Research

Clinical Decision-Making in Blood Pressure Management of Patients with Diabetes Mellitus: An Oklahoma Physicians Resource/Research Network (OKPRN) Study

Adam Cotton, Cheryl B. Aspy, James Mold and Howard Stein
The Journal of the American Board of Family Medicine May 2006, 19 (3) 232-239; DOI: https://doi.org/10.3122/jabfm.19.3.232

References

  1. ↵
    Contreras F, Rivera M, Vasquez J, De la Parte MA, Velasco M. Diabetes and hypertension physiopathology and therapeutics. J Hum Hypertens 2000; 14(Suppl 1): S26–31.
    OpenUrl
  2. ↵
    Geiss LS, Rolka DB, Engelgau MM. Elevated blood pressure among U.S. adults with diabetes, 1988–1994. Am J Prev Med Jan 2002; 22: 42–8.
    OpenUrl
  3. ↵
    UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317: 713–20.
    OpenUrlAbstract/FREE Full Text
  4. Arauz-Pacheco C, Parrott MA, Raskin P, American Diabetes Association. Hypertension management in adults with diabetes. Diabetes Care 2004; 27 Suppl 1: S65–7.
    OpenUrl
  5. Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36: 646–61.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Bakris GL. The importance of blood pressure control in the patient with diabetes. Am J Med 2004; 116 Suppl 5A: 30S–8S.
    OpenUrl
  7. ↵
    Berlowitz DR, Ash AS, Hickey EC, Glickman M, Friedman R, Kader B. Hypertension management in patients with diabetes: the need for more aggressive therapy. Diabetes Care 2003; 26: 355–9.
    OpenUrlAbstract/FREE Full Text
  8. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861–9.
    OpenUrlCrossRefPubMedWeb of Science
  9. Dagenais GR, Yusuf S, Bourassa MG, et al. Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study. Circulation 2001; 104: 522–6.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Gerstein HC. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE. Diabetes Metab Res Rev 2002; 18(Suppl 3): S82–5.
    OpenUrl
  11. ↵
    Kaplan NM. Management of hypertension in patients with type 2 diabetes mellitus: guidelines based on current evidence. Ann Intern Med 2001; 135: 1079–83.
    OpenUrlPubMedWeb of Science
  12. ↵
    Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002; 61: 1086–97.
    OpenUrlCrossRefPubMedWeb of Science
  13. Snow V, Weiss KB, Mottur-Pilson C. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Ann Intern Med 2003; 138: 587–92.
    OpenUrlPubMedWeb of Science
  14. ↵
    American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003; 26(Suppl 1): S33–50. Erratum in: Diabetes Care 2003;26:972.
    OpenUrl
  15. ↵
    Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–52.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Jonsson B, Hansson L, Stalhammar NO. Health economics in the Hypertension Optimal Treatment (HOT) study: costs and costeffectiveness of intensive blood pressure lowering and low-dose aspirin in patients with hypertension. J Intern Med 2003; 253: 472–80.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    Coon P, Zulkowski K. Adherence to American Diabetes Association standards of care by rural health care providers. Diabetes Care 2002; 25: 2224–9.
    OpenUrlAbstract/FREE Full Text
  18. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the “top 10” physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med 2003; 45: 5–14.
    OpenUrlCrossRefPubMedWeb of Science
  19. Miller CD, Phillips LS, Tate MK, et al. Meeting American Diabetes Association guidelines in endocrinologist practice. Diabetes Care 2000; 23: 444–8.
    OpenUrlAbstract
  20. ↵
    Oliveria SA, Lapuerta P, McCarthy BD, L’Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002; 162: 413–20.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001; 135: 825–34.
    OpenUrlCrossRefPubMedWeb of Science
  22. O’Connor PJ. Overcome clinical inertia to control systolic blood pressure. Arch Intern Med 2003; 163: 2677–8.
    OpenUrlCrossRefPubMedWeb of Science
  23. Reinharth D. Clinical inertia. Ann Intern Med 2002; 137: 547–8; author reply 547–8.
    OpenUrlPubMed
  24. Steinberg M. Clinical inertia. Ann Intern Med 2002; 137: 547–8; author reply 547–8.
    OpenUrlPubMed
  25. Wofford JL. Clinical inertia. Ann Intern Med 2002; 137: 547–8; author reply 547–8.
    OpenUrlPubMed
  26. ↵
    National Heart, Lung, and Blood Institute. Diagnosis and management of hypertension—1987: a nationwide survey of physicians’ knowledge, attitudes, and reported behavior. Bethesda: National Institutes of Health, U.S. Department of Health and Human Services; 1989. NIH Publications 89-2968.
  27. ↵
    Hofer TP, K. J. Zemencuk, Hayward RA. When there is too much to do: how practicing physicians prioritize among recommended interventions. J Gen Intern Med. 2004; 19: 646–53.
    OpenUrlPubMedWeb of Science
  28. ↵
    Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? JAMA 1999; 282: 1458–65.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    Mottur-Pilson C, Snow V, Bartlett K. Physician explanations for failing to comply with “best practice”. Eff Clin Pract 2001; 4: 207–13.
    OpenUrlPubMed
  30. ↵
    Parnes BL, Main DS, Dickinson LM, et al. Clinical decisions regarding HbA1c results in primary care: a report from CaReNet and HPRN. Diabetes Care 2004; 27: 13–6.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    James PA, Cowan TM, Graham RP. Patient-centered clinical decisions and their impact on physician adherence to clinical guidelines. J Fam Pract 1998; 46: 311–8.
    OpenUrlPubMedWeb of Science
  32. ↵
    Andrade SE, Gurwitz JH, Field TS, et al. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Managed Care 2004; Jul 10(7 Pt 2): 481–6.
    OpenUrl
  33. ↵
    Cook CB, Ziemer DC, El-Kebbi IM, et al. Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care 1999; 22: 1494–500.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Ferrari P, Hess L, Pechere-Bertschi A, Muggli F, Burnier M. Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study. J Hypertens 2004; 22: 1221–9.
    OpenUrlCrossRefPubMedWeb of Science
  35. ↵
    Jaen CR, Stange KC, Tumiel LM, Nutting P. Missed opportunities for prevention: smoking cessation counseling and the competing demands of practice. J Fam Pract 1997; 45: 348–54.
    OpenUrlPubMedWeb of Science
  36. Barnes CS, Ziemer DC, Miller CD, et al. Little time for diabetes management in the primary care setting. Diabetes Educator 2004; 30: 126–35.
    OpenUrlFREE Full Text
  37. Kikano GE, Zyzanski SJ, Gotler RS, Stange KC. High-volume practice: are there trade-offs? Fam Pract Manage 2000; 7: 63–4.
    OpenUrlPubMed
  38. Zyzanski SJ, Stange KC, Langa D, Flocke SA. Trade-offs in high-volume primary care practice. J Fam Pract 1998; 46: 397–402.
    OpenUrlPubMedWeb of Science
  39. ↵
    Knight T, Leech F, Jones A, et al. Sphygmomanometers in use in general practice: an overlooked aspect of quality in patient care. J Hum Hypertens 2001; 15: 681–4.
    OpenUrlCrossRefPubMed
  40. ↵
    Pedone C, Lapane KL. Generalizability of guidelines and physicians’ adherence. Case study on the Sixth Joint National Commitee’s guidelines on hypertension. BMC Public Health 2003; 3: 24.
    OpenUrlPubMed
  41. ↵
    Worrall G, Chaulk P, Freake D. The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review. Can Med Assoc J 1997; 156: 1705–12.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Werner RM, Asch DA. The unintended consequences of publicly reporting quality information. JAMA 2005; 293: 1239–43.
    OpenUrlCrossRefPubMedWeb of Science
  43. Hofer TP, Hayward RA, Greenfield S, Wagner EH, Kaplan SH, Manning WG. The unreliability of individual physician “report cards” for assessing the costs and quality of care of a chronic disease. JAMA 1999; 281: 2098–105.
    OpenUrlCrossRefPubMedWeb of Science
  44. Werner RM, Asch DA, Polsky D. Racial profiling: the unintended consequences of coronary artery bypass graft report cards. Circulation 2005; 111: 1257–63.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section